MannKind gets $160m debt facility as Afrezza data loom
This article was originally published in Scrip
Executive Summary
MannKind entered into debt financing with affiliates of Deerfield Management in which the investment management firm will buy up to $160 million in senior secured notes in four different tranches tied to certain milestones for the Valencia, California-based drug developer's inhaled insulin Afrezza.